Citigroup
FBT icon

Citigroup’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Citigroup’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Sell
13,767
-73
-0.5% -$15.1K ﹤0.01% 2441
2025
Q4 		$2.86M Buy
13,840
+1,002
+8% +$200K ﹤0.01% 2418
2025
Q3 		$2.3M Buy
12,838
+677
+6% +$115K ﹤0.01% 2562
2025
Q2 		$1.96M Sell
12,161
-453
-4% -$72.2K ﹤0.01% 2664
2025
Q1 		$2.15M Sell
12,614
-1,872
-13% -$325K ﹤0.01% 2636
2024
Q4 		$2.41M Sell
14,486
-4,576
-24% -$782K ﹤0.01% 2657
2024
Q3 		$3.28M Sell
19,062
-1,045
-5% -$173K ﹤0.01% 2215
2024
Q2 		$3.1M Buy
20,107
+4,564
+29% +$685K ﹤0.01% 1996
2024
Q1 		$2.39M Buy
15,543
+3,121
+25% +$476K ﹤0.01% 2296
2023
Q4 		$1.96M Sell
12,422
-1,552
-11% -$223K ﹤0.01% 2254
2023
Q3 		$2.05M Buy
13,974
+1,607
+13% +$245K ﹤0.01% 1964
2023
Q2 		$1.89M Buy
12,367
+224
+2% +$34.9K ﹤0.01% 2268
2023
Q1 		$1.88M Sell
12,143
-561
-4% -$88.1K ﹤0.01% 2062
2022
Q4 		$1.96M Sell
12,704
-3,008
-19% -$444K ﹤0.01% 2055
2022
Q3 		$2.07M Sell
15,712
-911
-5% -$128K ﹤0.01% 2115
2022
Q2 		$2.25M Sell
16,623
-772
-4% -$106K ﹤0.01% 2019
2022
Q1 		$2.59M Buy
17,395
+33
+0.2% +$4.88K ﹤0.01% 2154
2021
Q4 		$2.81M Buy
17,362
+842
+5% +$136K ﹤0.01% 2332
2021
Q3 		$2.74M Sell
16,520
-8,470
-34% -$1.45M ﹤0.01% 2284
2021
Q2 		$4.31M Buy
24,990
+493
+2% +$81.4K ﹤0.01% 2022
2021
Q1 		$3.93M Buy
24,497
+798
+3% +$137K ﹤0.01% 1968
2020
Q4 		$3.98M Buy
23,699
+1,655
+8% +$268K ﹤0.01% 2257
2020
Q3 		$3.47M Sell
22,044
-522
-2% -$85.3K ﹤0.01% 2172
2020
Q2 		$3.79M Buy
22,566
+522
+2% +$81.9K ﹤0.01% 2126
2020
Q1 		$2.89M Sell
22,044
-2,049
-9% -$292K ﹤0.01% 2134
2019
Q4 		$3.58M Sell
24,093
-2,957
-11% -$406K ﹤0.01% 2338
2019
Q3 		$3.35M Sell
27,050
-1,742
-6% -$232K ﹤0.01% 2313
2019
Q2 		$4.05M Buy
28,792
+2,399
+9% +$331K ﹤0.01% 2154
2019
Q1 		$3.98M Buy
26,393
+868
+3% +$125K ﹤0.01% 1990
2018
Q4 		$3.17M Buy
25,525
+2,263
+10% +$309K ﹤0.01% 2254
2018
Q3 		$3.69M Buy
23,262
+5,178
+29% +$784K ﹤0.01% 2154
2018
Q2 		$2.53M Buy
18,084
+1,800
+11% +$247K ﹤0.01% 2482
2018
Q1 		$2.16M Buy
16,284
+3,087
+23% +$421K ﹤0.01% 2521
2017
Q4 		$1.64M Buy
13,197
+987
+8% +$122K ﹤0.01% 2867
2017
Q3 		$1.51M Buy
12,210
+1,865
+18% +$221K ﹤0.01% 2944
2017
Q2 		$1.18M Buy
10,345
+718
+7% +$77.2K ﹤0.01% 3136
2017
Q1 		$1.01M Buy
9,627
+5,753
+149% +$577K ﹤0.01% 3195
2016
Q4 		$352K Buy
3,874
+669
+21% +$62.7K ﹤0.01% 4749
2016
Q3 		$320K Buy
3,205
+60
+2% +$5.89K ﹤0.01% 4296
2016
Q2 		$281K Sell
3,145
-3,825
-55% -$351K ﹤0.01% 4188
2016
Q1 		$611K Sell
6,970
-22,584
-76% -$1.99M ﹤0.01% 3908
2015
Q4 		$3.34M Buy
29,554
+3,756
+15% +$404K ﹤0.01% 2067
2015
Q3 		$2.61M Buy
25,798
+5,355
+26% +$637K ﹤0.01% 2221
2015
Q2 		$2.54M Buy
20,443
+8,978
+78% +$1.08M ﹤0.01% 2311
2015
Q1 		$1.36M Buy
11,465
+6,463
+129% +$731K ﹤0.01% 2822
2014
Q4 		$510K Buy
5,002
+2,900
+138% +$283K ﹤0.01% 3869
2014
Q3 		$193K Buy
2,102
+359
+21% +$31.1K ﹤0.01% 4266
2014
Q2 		$144K Buy
1,743
+342
+24% +$26.1K ﹤0.01% 4393
2014
Q1 		$107K Sell
1,401
-1,488
-52% -$116K ﹤0.01% 4925
2013
Q4 		$200K Buy
2,889
+196
+7% +$12.9K ﹤0.01% 4657
2013
Q3 		$175K Buy
2,693
+2,276
+546% +$144K ﹤0.01% 4267
2013
Q2 		$24K Buy
+417
New +$23.8K ﹤0.01% 5744

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Citigroup's FBT Position: Q1 2026 in Review

Citigroup reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.53% in Q1 2026, selling an estimated $15.1K and leaving 13,767 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

Citigroup first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.31M in Q2 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Citigroup held 13,767 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.76M as of Q1 2026.
  • Citigroup sold 73 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $15.1K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2441 holding.
  • Citigroup first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.31M in Q2 2021.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.